Pharmabiz24m
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis
CAGE Bio begins phase 2b clinical trial for CGB-500, a breakthrough topical JAK inhibitor for moderate to severe atopic dermatitis: San Carlos, California Saturday, January 11, 20 ...
Pharmabiz2h
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea
Newron Pharma, Myung In Pharm ink license agreement to develop, manufacture & commercialize Newron’s evenamide in South Korea: Milan Saturday, January 11, 2025, 16:00 Hrs [IST] ...
Pharmabiz1h
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025
FORE Biotherapeutics highlights pipeline achievements for its oncology programme; Provides objectives for 2025: Philadelphia Saturday, January 11, 2025, 17:00 Hrs [IST] FORE Bioth ...
Pharmabiz3h
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart
SynCardia Systems gets CNIPA notification granting first patent covering company’s next-generation total artificial heart: Tucson, Arizona Saturday, January 11, 2025, 15:00 Hrs ...
Pharmabiz4h
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market
Gaelic Labs establishes subsidiary in UAE, enabling access to growing Middle East pharma market: Ireland Saturday, January 11, 2025, 13:30 Hrs [IST] Gaelic Laboratories, a Europea ...
Pharmabiz4h
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology
Boehringer Ingelheim broadens oncology portfolio with license for Synaffix’s ADC technology: Ingelheim Saturday, January 11, 2025, 14:00 Hrs [IST] Boehringer Ingelheim and Synaf ...
Pharmabiz6h
US FDA grants priority review status to Johnson & Johnson’s nipocalimab BLA to treat generalized myasthenia gravis
Spring House, Pennsylvania Saturday, January 11, 2025, 12:00 Hrs [IST] ...
Pharmabiz5h
Seven research leaders awarded prestigious NIHR award
The NIHR has announced the latest outstanding researchers to become NIHR Research Professors. They will play a key role in undertaking professorial-level research that has a positive impact on the ...
Pharmabiz5d
CDSCO releases draft standard evaluation protocols for issuing license for IVDs
The Central Drugs Standard Control Organisation (CDSCO) and Indian Council of Medical Research (ICMR) have together released the draft standard evaluation protocols for the purpose of issuing license ...
Pharmabiz5d
CIPI chairman says the pharma MSME sector had expected unconditional extension and financial aid from the government
Responding to the draft notification issued by the union health ministry last Saturday, the chairman of the Confederation of Indian Pharmaceutical Industries (CIPI), R K Jain, has commented that the ...
Pharmabiz5d
KPRDO seeks Centre’s intervention to for reimbursement on cut strips of expiry dated medicines
The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has urged the Union health ministry for reimbursement for cut strips of expiry dated medicines. In a communication to the Ministry ...
Pharmabiz5d
Indian pharma needs regulations of less prescriptive nature: Dr DBA Narayana
Indian pharmaceutical companies are operating in a highly regulated environment, with rules and compliance standards often being prescriptive. While these regulations are essential to ensure quality, ...